P1178: THE APPLICABILITY OF PROGNOSTIC MODELS UNDER RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): A COMPARISON WITH R-CHOP

por Vassilakopoulos, Theodoros, Ferhanoglu, B, Horowitz, Na, Apostolidis, J, Mellios, Z, Piperidou, Alexia, Kaynar, L, Zektser, M, Giotasmater, A, Hospital, Dei, Malta, Msida, Symeonidis, A, Kalpadakis, C, Agathocleous, A, Akay, Om, Sayyed, A, Atalar, Sc, Katodritou, E, Leonidopoulou, T, Papageorgiou, Sg, Tadmor, T., Gutwein, O, Karakatsanis, S, Ganzel, C, Karianakis, G., Isenberg, G. Y., Gainaru, G, Vrakidou, E., Palassopoulou, M, Ozgur, M, Siakantaris, Marina, Paydas, S, Tsirigotis, P, Tsirogianni, M, Hatzimichael, E, Tugular, Tf, Assimakopoulos, Jv, Ligdi, L, Liaskas, A, Aikaterini Lefaki, Maria, Labropoulou, P, Kopsaftopoulou, A, Verrou, E, Kanellias, M, Zikos, P, Koumarianou, A, Gafter-Gvili, A, Bouzani, M, Angelopoulou, Mk, Karmiris, T, Gurion, R
Publicado 2023